NPPA revised Retail Price of 93 scheduled formulations: January 2023

Download NPPA notification No. S.O. S.O. 87(E) dt 06-01-2023

3024
NPPA National Pharmaceutical Pricing Authority
Picture: Pixabay

Last Updated on December 31, 2023 by The Health Master

Download NPPA notification No. S.O. S.O. 87(E) dt 06-01-2023, the link is given below: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, has fixed the retail price of 4 scheduled formulations vide vide S.O. 87(E) dt 06-01-2023 based on the decision of 106th Authority meeting dated 30.12.2022

This price fixation followed the decision of the 106th Authority meeting on December 30, 2022.

In exercise of the powers conferred by paragraphs 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated 30th May, 2013 and S.O. 5249(E) dated 11th November, 2022 issued by the Government of India the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No SO
1499(E) dated 30th March, 2022 in so far as it relates to formulation packs mentioned in the table below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table herein below as ceiling price exclusive of goods
and services tax applicable, if any, in respect of the Scheduled formulation specified in the corresponding entry in column (2) of the said Table with the dosage form & strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof:

Table

Sl. No.Name of the Scheduled Formulation  Dosage form and strength  UnitCeiling Price (Rs.)
(1)(2)(3)(4)(5)
1SulfasalazineTablet 500 mg1 Tablet4.21
2DigoxinTablet 0.25mg1 Tablet1.19
3EthambutolTablet 600mg1 Tablet3.64
4PhenytoinTablet 300mg1 Tablet4.89
  5Atazanavir (A) +Ritonavir(B)Tablet 300mg(A) + Tablet 100mg(B)  1 Tablet  89.03
6CeftriaxonePowder for Injection 500 mg1 Vial44.84
7CeftriaxonePowder for Injection 250 mg1 Vial25.28
8CeftriaxonePowder for Injection 1000mg1 Vial55.64
9CeftriaxonePowder for Injection 2000mg1 Vial123.18
10CefotaximePowder for Injection 250 mg1 Vial15.80
11CefotaximePowder for Injection 500 mg1 Vial21.74
12CefotaximePowder for Injection 1000mg1 Vial35.64
  13Piperacillin (A) +Tazobactam(B)Powder for Injection 1000mg(A)+125mg(B)  1 Vial  88.88
  14Piperacillin (A) +Tazobactam(B)Powder for Injection 2000mg(A)+250mg(B)  1 Vial  170.83
  15Piperacillin (A) +Tazobactam(B)Powder for Injection 4000mg(A)+500mg(B)  1 Vial  356.21
16AmpicillinPowder for Injection 500 mg1 Vial12.71
17MetoprololTablet 25mg1 Tablet3.75
18MetoprololTablet 50mg1 Tablet5.21
19PropranololTablet 40mg1 Tablet2.87
20FluconazoleTablet 200mg1 Tablet15.57
21EthambutolTablet 800mg1 Tablet4.42
22PyrazinamideTablet 1000mg1 Tablet9.39
23PyrazinamideTablet 500mg1 Tablet4.36
24PyrazinamideTablet 750mg1 Tablet6.43
25PhenobarbitoneTablet 30mg1 Tablet1.17
26AmiodaroneTablet 200mg1 Tablet10.27
27EthambutolTablet 400mg1 Tablet2.33
28FluconazoleTablet 100mg1 Tablet6.80
29AzathioprineTablet 50mg1 Tablet10.04
30AllopurinolTablet 100mg1 Tablet1.69
31PropranololTablet 10mg1 Tablet1.17
32HydroxychloroquineTablet 200mg1 Tablet5.67
33CarbimazoleTablet 10mg1 Tablet3.80
34CefiximeTablet 200mg1 Tablet8.72
35ImatinibTablet 100mg1 Tablet62.21
36TamoxifenTablet 20mg1 Tablet2.63
37TamoxifenTablet 10mg1 Tablet1.97
38L-AsparaginasePowder for Injection 5000 KU1 Vial922.94
  39  L-AsparaginasePowder for Injection 10000KU  1 Vial  1523.03
40DacarbazinePowder for Injection 200mg1 Vial340.46
41MefloquineTablet 250 mg1 Tablet46.52
42ThalidomideCapsule 50 mg1 Capsule27.79
43ThalidomideCapsule 100mg1 Capsule55.31
44ClonazepamTablet 0.25mg1 Tablet1.80
45ClonazepamTablet 0.5mg1 Tablet3.08
46ClonazepamTablet 1mg1 Tablet4.25
47ClozapineTablet 25mg1 Tablet2.48
48ClozapineTablet 50mg1 Tablet4.63
49ClozapineTablet 100 mg1 Tablet7.54
50MetronidazoleTablet 200mg1 Tablet0.73
51MetronidazoleTablet 400mg1 Tablet1.36
52HydroxyureaCapsule 500mg1 Capsule10.81
53IbuprofenTablet 200mg1 Tablet0.63
54AcetazolamideTablet 250mg1 Tablet3.62
55CiprofloxacinTablet 250mg1 tablet1.96
56SalbutamolTablet 4 mg1 Tablet0.19
57SalbutamolTablet 2 mg1 Tablet0.16
58MetoclopramideTablet 10mg1 Tablet1.20
  59Amoxicillin (A) +Clavulanic acid (B)Tablet 500 mg (A) + 125 mg (B)  1 Tablet  16.32
60DocetaxelPowder for Injection 20mg1 Vial2558.14
61ClopidogrelTablet 75mg1 Tablet5.94
62HydrocortisonePowder for Injection 100mg1 Vial39.95
63GemcitabinePowder for Injection 1000mg1 Vial4987.65
64MethotrexateTablet 10mg1 tablet11.85
65MethotrexateTablet 2.5mg1 tablet4.74
66DiltiazemTablet 60mg1 Tablet4.87
67AmiodaroneTablet 100mg1 Tablet5.48
68Dom1idoneTablet 10mg1 Tablet2.06
69QuinineTablet 300 mg1 Tablet5.04
70EnalaprilTablet 5mg1 Tablet3.30
71EnalaprilTablet 2.5mg1 Tablet1.95
72AcyclovirTablet 400mg1 Tablet12.18
73AcyclovirTablet 200mg1 Tablet6.79
74RifampicinCapsule 450mg1 Capsule5.06
  75Zidovudine (A) +Lamivudine(B)  Tablet 300mg(A)+150mg(B)  1 Tablet  18.81
76PrimaquineTablet 7.5mg1 Tablet2.12
77NitrofurantoinTablet 100 mg1 Tablet7.23
78CiprofloxacinTablet 500mg1 tablet3.79
79OndansetronTablet 8 mg1 Tablet7.94
80GriseofulvinTablet 250mg1 Tablet1.58
81EscitalopramTablet 5mg1 Tablet4.48
82EscitalopramTablet 10mg1 Tablet8.03
83EscitalopramTablet 20mg1 Tablet12.81
84GemcitabinePowder for Injection 200 mg1 Vial1159.21
85CeftazidimePowder for Injection 1000mg1 Vial202.47
86DiclofenacTablet 50mg1 Tablet1.83
87CarbamazepineTablet 200mg1 Tablet1.40
  88Amoxicillin (A) + Clavulanic acid (B)Powder for Injection 1 g (A) +200mg (B)  1 Vial  125.44
89BisacodylTablet 5mg1 Tablet1.04
90PantoprazoleInjection 40mg1 Vial45.00
  91Ethinylestradiol (A)+ Levonorgestrel (B)Tablet 0.03mg(A) + Tablet 0.15mg(B)  1 Tablet  2.83
92NorethisteroneTablet 5mg1 Tablet4.81
93CarbimazoleTablet 5mg1 Tablet1.95

Note:
(a) All manufacturers of scheduled formulation, selling the branded or generic or both the versions of scheduled formulations at a price higher than the ceiling price (plus Goods and Services Tax as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any.

(b) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013.

(c) The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above-said table.

(d) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO 2013.

The manufacturer shall issue a price list in Form–V from the date of the Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(e) As per para 24(4) of DPCO 2013, every retailer and dealer shall display the price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner to be easily accessible to any person wishing to consult the same.

(f) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule II of the DPCO, 2013.

(g) The manufacturers of above said scheduled formulations shall furnish quarterly returns to the NPPA, in respect of the production/import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS.

Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and/or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.

(h) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the DPCO 2013 read with Essential Commodities Act, 1955.

(i) Consequent to the issue of the ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above-said date of notification, stand(s) superseded.

Latest on National Pharmaceutical Pricing Authority (NPPA)

Latest notifications – DPCO / NPPA

NPPA updated price lists: Download

Latest Notifications: EC Act (Essential Commodities Act)

FAQs – On DPCO: Drugs (Prices Control) Order, 2013

National List of Essential Medicines (NLEM)

NPPA fixes Retail Price of 4 scheduled formulations: January 2023

NPPA fixes retail price of 36 formulations: January 2023

NPPA fixes Retail Price of 10 formulations: December 2022

NPPA fixes Retail Price of 12 scheduled formulations: December 2022

NPPA revises Retail Price of 107 scheduled formulations: December 2022

NPPA fixes Retail Price of one formulation: November 2022

USFDA issues warning letter to Sun Pharma for its Gujarat plant

Tramadol: 3 Pharmaceutical Companies under scanner

NMC allows foreign medical graduates to finish internship in India

NABL suspends accreditation of 80 laboratories

NPPA fixes Retail Price of 4 scheduled formulations: January 2023

Medical Oxygen plants to be put on digital map

JIPMER: Nursing Officer 2022 result declared, Download

List of approved FDCs (Fixed Dose Combinations) Updated

List of approved New Drugs Updated

Latest Notifications regarding Pharmaceutical

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news